Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,151,270
+$289,556 QoQ
Shares Held
8,549
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,910
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Westover Capital Advisors, LLC holds $13,813,106 across 9 Drug Manufacturers - General names. ABBV ranks #2 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,728 | $4,471,475 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
8,549 | $2,151,270 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
15,885 | $2,006,910 | |
| 4 | JNJ |
Johnson & Johnson
|
6,016 | $1,527,883 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,716 | $1,505,506 | |
| 6 | AMGN |
Amgen Inc
|
2,375 | $860,035 | |
| 7 | AZN |
Astrazeneca PLC
|
4,458 | $845,325 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,182 | $240,966 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,151,270 | 8,549 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,861,714 | 8,560 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,005,228 | 8,776 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,040,562 | 8,813 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,654,431 | 8,913 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,868,080 | 8,916 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,013,874 | 11,333 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,246,137 | 11,374 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,002,324 | 11,674 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,634,893 | 8,978 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,421,074 | 9,170 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,310,237 | 8,790 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,269,156 | 9,420 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,504,134 | 9,438 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $1,525,598 | 9,440 | Shares | Sole | 2023-05-18 | |
| 2022-09-30 | $1,268,284 | 9,450 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,649,686 | 10,771 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,083,867 | 6,686 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $890,255 | 6,575 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $834,374 | 7,735 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $841,195 | 7,468 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $830,696 | 7,676 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $839,841 | 7,838 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $753,799 | 8,606 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $831,584 | 8,470 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $649,900 | 8,530 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||